Akdeniz University Medical Faculty
Antalya, Turkey
Dental school in Antalya
P.K.10 Dumlupınar Bulvarı Kampüs, 07058 Konyaaltı/Antalya
About Akdeniz University Medical Faculty
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
17
Janssen Research & Development, LLC
7
Eli Lilly and Company
5
Agios Pharmaceuticals, Inc.
2
AstraZeneca Turkey
2
Baxalta now part of Shire
2
Camurus AB
2
Celgene
2
Diskapi Teaching and Research Hospital
2
Health Institutes of Turkey
2
Actelion
1
Clinical Trials at Akdeniz University Medical Faculty
During the past decade, Akdeniz University Medical Faculty conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 20 clinical trials were completed, i.e. on
average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 12 clinical trials were completed. i.e. 54.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"
2013-08-06
2018-09-06
Completed
287
A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
2014-02-21
2018-11-25
Completed
174
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Akdeniz University Medical Faculty" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Janssen Research & Development, LLC" with 7 trials
sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "AstraZeneca Turkey"
with 2 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Akdeniz University Medical Faculty"
#1 collaborator was "Klinar CRO" with 3 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "CenTrial GmbH" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Akdeniz University Medical Faculty
According to Clinical.Site data, the most researched conditions in "Akdeniz University Medical Faculty" are
"Breast Cancer" (5 trials), "Arthritis, Psoriatic" (3 trials), "Breast Neoplasms" (3 trials), "Hemophilia A" (3 trials) and "Idiopathic Pulmonary Fibrosis" (3 trials). Many other conditions were trialed in "Akdeniz University Medical Faculty" in a lesser frequency.
Clinical Trials Intervention Types at Akdeniz University Medical Faculty
Most popular intervention types in "Akdeniz University Medical Faculty" are "Drug" (47 trials), "Other" (10 trials), "Biological" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Cisplatin" (5 trials), "Docetaxel" (5 trials), "Capecitabine" (4 trials) and "Cyclophosphamide" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Akdeniz University Medical Faculty
The vast majority of trials in "Akdeniz University Medical Faculty" are
58 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Akdeniz University Medical Faculty
Currently, there are NaN active trials in "Akdeniz University Medical Faculty".
undefined are not yet recruiting,
12 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Akdeniz University Medical Faculty,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Akdeniz University Medical Faculty, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 41 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".